The Capability Papers:

Digital Health, Biotech & Medtech



There is nothing like a pandemic to throw a light on the complexity and vulnerability of our health and medical supply chains. Australia has huge capability across medtech, digital health and biotech – but it can be slow to market, and can slip under the radar when purchasing decisions are made. There is no denying that our research capability is world class, but there is newfound urgency to take this IP to domestic and international markets.

This forum will explore the ecosystem that includes advanced manufacturing, digital health platforms, biotech and vaccine development. Where do we have capability, where do we partner and where are our customer markets?


More details to come. Watch this space.